Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd™
Quantum BioPharma (NASDAQ: QNTM) announced that its licensee Celly Nutrition has formed a strategic partnership with the Asian American Trade Associations Council (AATAC) to expand the retail distribution of unbuzzd™, their alcohol detox beverage.
The partnership focuses on unbuzzd™'s On-the-Go Powder Stick Packs, which are scientifically proven to accelerate blood alcohol level reduction and restore mental alertness. AATAC represents over 50,000 members operating more than 80,000 locations, including major convenience store chains like 7-Eleven, Shell, Circle K, and BP.
This collaboration aims to increase sales and product accessibility across the United States and Puerto Rico, leveraging AATAC's extensive network of convenience stores and their experience in launching successful consumer goods products.
Quantum BioPharma (NASDAQ: QNTM) ha annunciato che il suo licenziatario Celly Nutrition ha stretto una partnership strategica con il Consiglio delle Associazioni Commerciali Americane Asiatiche (AATAC) per espandere la distribuzione al dettaglio di unbuzzd™, la loro bevanda per la disintossicazione dall'alcol.
La partnership si concentra sui Pack di Polvere On-the-Go di unbuzzd™, che sono scientificamente provati per accelerare la riduzione del livello di alcol nel sangue e ripristinare la lucidità mentale. AATAC rappresenta oltre 50.000 membri che operano più di 80.000 punti vendita, comprese grandi catene di negozi di convenienza come 7-Eleven, Shell, Circle K e BP.
Questa collaborazione mira ad aumentare le vendite e l'accessibilità del prodotto negli Stati Uniti e a Porto Rico, sfruttando l'ampia rete di negozi di convenienza di AATAC e la loro esperienza nel lanciare prodotti di consumo di successo.
Quantum BioPharma (NASDAQ: QNTM) anunció que su licenciatario Celly Nutrition ha formado una asociación estratégica con el Consejo de Asociaciones Comerciales Asiático-Americanas (AATAC) para expandir la distribución minorista de unbuzzd™, su bebida para la desintoxicación del alcohol.
La asociación se centra en los Paquetes de Polvo On-the-Go de unbuzzd™, que están científicamente comprobados para acelerar la reducción del nivel de alcohol en sangre y restaurar la alerta mental. AATAC representa a más de 50,000 miembros que operan más de 80,000 ubicaciones, incluidas grandes cadenas de tiendas de conveniencia como 7-Eleven, Shell, Circle K y BP.
Esta colaboración tiene como objetivo aumentar las ventas y la accesibilidad del producto en los Estados Unidos y Puerto Rico, aprovechando la amplia red de tiendas de conveniencia de AATAC y su experiencia en el lanzamiento de productos de consumo exitosos.
Quantum BioPharma (NASDAQ: QNTM)는 그 라이센스 보유자인 Celly Nutrition이 아시아계 미국인 상공 회의소(AATAC)와 전략적 파트너십을 체결하여 그들의 알코올 해독 음료인 unbuzzd™의 소매 유통을 확대했다고 발표했습니다.
이번 파트너십은 혈중 알코올 농도 감소를 가속화하고 정신적 경각심을 회복하는 것으로 과학적으로 입증된 unbuzzd™의 온더고 파우더 스틱 팩에 중점을 두고 있습니다. AATAC은 50,000명 이상의 회원을 대표하며, 7-Eleven, Shell, Circle K, BP와 같은 주요 편의점 체인을 포함하여 80,000개 이상의 위치에서 운영되고 있습니다.
이번 협력은 AATAC의 광범위한 편의점 네트워크와 소비재 제품 출시 경험을 활용하여 미국과 푸에르토리코 전역에서 판매와 제품 접근성을 높이는 것을 목표로 하고 있습니다.
Quantum BioPharma (NASDAQ: QNTM) a annoncé que son licencié Celly Nutrition a formé un partenariat stratégique avec le Conseil des Associations Commerciales Américaines Asiatiques (AATAC) pour étendre la distribution au détail de unbuzzd™, leur boisson détox alcool.
Le partenariat se concentre sur les Sachets de Poudre On-the-Go de unbuzzd™, qui sont scientifiquement prouvés pour accélérer la réduction du taux d'alcool dans le sang et restaurer la vigilance mentale. AATAC représente plus de 50 000 membres opérant plus de 80 000 points de vente, y compris de grandes chaînes de magasins de proximité comme 7-Eleven, Shell, Circle K et BP.
Cette collaboration vise à augmenter les ventes et l'accessibilité du produit à travers les États-Unis et Porto Rico, en s'appuyant sur l'étendue du réseau de magasins de proximité d'AATAC et leur expérience dans le lancement de produits de consommation réussis.
Quantum BioPharma (NASDAQ: QNTM) gab bekannt, dass sein Lizenznehmer Celly Nutrition eine strategische Partnerschaft mit dem Asiatisch-Amerikanischen Handelsverband (AATAC) eingegangen ist, um den Einzelhandel von unbuzzd™, ihrem Alkohol-Entgiftungsgetränk, auszubauen.
Der Schwerpunkt der Partnerschaft liegt auf den On-the-Go-Pulverstickpackungen von unbuzzd™, die wissenschaftlich nachgewiesen die Reduzierung des Blutalkoholspiegels beschleunigen und die geistige Wachsamkeit wiederherstellen. AATAC vertritt über 50.000 Mitglieder, die mehr als 80.000 Standorte betreiben, darunter große Convenience-Store-Ketten wie 7-Eleven, Shell, Circle K und BP.
Diese Zusammenarbeit zielt darauf ab, den Umsatz und die Produktverfügbarkeit in den Vereinigten Staaten und Puerto Rico zu steigern, indem das umfangreiche Netzwerk von AATAC an Convenience-Stores und deren Erfahrung bei der Einführung erfolgreicher Konsumgüterprodukte genutzt wird.
- Partnership grants access to massive retail network of 80,000+ locations
- Distribution through major convenience store chains increases product visibility and accessibility
- Expansion into established retail network could significantly boost sales potential
- Product placement in growing health and wellness category with proven market demand
- Success depends on actual adoption by individual retailers within AATAC network
- No guaranteed minimum purchase commitments mentioned in the partnership
Insights
This partnership with AATAC represents a significant distribution breakthrough for unbuzzd™ that could substantially expand its retail footprint. Access to AATAC's network of over 80,000 locations including major chains like 7-Eleven and Circle K positions the product in high-traffic environments perfectly aligned with potential customer need-states.
The strategic focus on powder stick packs is particularly shrewd for the convenience channel, where grab-and-go formats command premium pricing and higher margins. Convenience stores have emerged as powerful distribution points for functional beverages, with recovery products showing exceptional growth in this segment according to AATAC's National Programs Director.
What's particularly valuable here is AATAC's track record of successfully launching innovative products that have achieved category leadership. Their endorsement signals both confidence in the product and provides the critical infrastructure needed to overcome the distribution hurdles that typically constrain growth for emerging consumer products.
However, execution will be critical - the announcement doesn't specify rollout timing, store placement targets, or merchandising support. While the potential reach is impressive, actual penetration across the full network will likely develop gradually rather than simultaneously across all 80,000 locations.
For Quantum BioPharma shareholders, this partnership's value depends entirely on the structure of their licensing agreement with Celly Nutrition, which remains undisclosed. Typical licensing arrangements in the consumer health space range from 5-15% royalty rates on wholesale revenue, possibly with minimum guaranteed payments.
The absence of financial projections or terms makes quantifying the near-term impact impossible, but the structural value is clear: AATAC partnerships dramatically reduce the customer acquisition costs and promotional investments typically required to build retail distribution networks organically.
Convenience store distribution aligns perfectly with the product's use case and could accelerate adoption rates compared to traditional retail channels. The recovery beverage segment has seen multiple brands achieve $50-100M+ valuations following successful convenience channel launches.
For a company with Quantum's
TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today announced its licensee – Celly Nutrition Corporation (“Celly Nutrition”), the company behind unbuzzd™ – the beverage that accelerates alcohol metabolism, restores mental clarity, and reduces hangover symptoms – has secured a landmark partnership with the Asian American Trade Associations Council (“AATAC”) to expand the retail availability of unbuzzd™, increase sales, and recruit new customers. This partnership will focus on unbuzzd™’s convenient “On-the-Go Powder Stick Packs” which have been scientifically proven to accelerate the reduction of blood alcohol levels and restore mental alertness.
AATAC is made up of smaller buying groups, regional sub-chapters, and other trade organizations that represent over 50,000 members who collectively operate more than 80,000 locations, including over half of all convenience stores across the United States and Puerto Rico. Brands in the AATAC network include 7-Eleven, Shell, Circle K, ampm, Texaco, BP, 76, Sunoco, Gulf, and Chevron, among many others. AATAC has played an important role in launching innovative new products into the retail space, many of which have reached the highest levels of retail sales in the consumer goods category.
John Duffy, CEO of Celly Nutrition, stated, “We are excited to partner with AATAC to further expand unbuzzd™'s retail presence. This collaboration provides access to top retail operators across the United States, helping to grow sales and making unbuzzd™ available to even more consumers.”
Sunil Capita, National Programs Director of AATAC, added, “The health and wellness category has grown significantly over recent years in our industry, and recovery products have become a leader within that category. Understandably, our Association wants to be at the forefront of this evolving trend, so we are very excited to see how well unbuzzd™ will perform in our retail sites. We would eventually like to see recovery products offered to U.S. consumers by thousands of our network retailers across the country.”
About AATAC
AATAC is a national association consisting of regional sub-chapters, smaller buying groups, independents, and trade affiliates that collectively represent over 80,000 locations across the United States. AATAC empowers its retailers by educating them on market trends and directly introducing vendor suppliers and programs that allow them to stay relevant and competitive in the industry. AATAC’s DRIP program allows approved products to obtain hundreds of retail accounts within a matter of weeks. Visit aatac.co/services for more information.
About Celly Nutrition Corporation
Celly Nutrition, a non-trading but fully-reporting public issuer, stands as a pioneering force in the wellness and recovery supplement landscape. unbuzzd™ has been developed by a world-class research and development team in pharmacology and medicine, with a commitment to innovation and quality. With a proprietary blend of vitamins, minerals, and herbs, unbuzzd™ helps your body process alcohol faster, restore mental alertness, and improve cognition so you can drink responsibly. unbuzzd™ appeals to a broad target audience of alcohol consumers who want to have a good time, be in control, and still feel great the next day.
Scientifically backed by a recently completed double-blind, randomized, placebo-controlled crossover design clinical trial, unbuzzd™ dramatically accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration, restores mental clarity, and reduces the symptoms of intoxication, impairment and hangover. The full press release of the clinical trial can be found here.
unbuzzd™ ready-to-mix powder sticks are available in 3-pack, 8-pack and 18-pack formats at amazon.com and unbuzzd.com.
unbuzzd™ is a registered trademark of Celly Nutrition Corp.
Individual results may vary. unbuzzd is a dietary supplement. Consuming unbuzzd after drinking alcohol does not permit you to operate a vehicle. Drink responsibly. DO NOT DRINK AND DRIVE.
About Quantum BioPharma Ltd.
Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), Quantum BioPharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum BioPharma invented UNBUZZD™ and spun out its OTC version to a company, Celly Nutrition Corp. (“Celly Nutrition”), led by industry veterans. Quantum BioPharma retains ownership of
Forward-Looking Information
Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include statements related to such.
Forward-looking information in this press release are based on certain assumptions and expected future events.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to additional information relating to Quantum BioPharma, including its annual information form, can be located on the SEDAR+ website at www.sedarplus.ca and on the EDGAR section of the United States Securities and Exchange Commission’s website at www.sec.gov for a more complete discussion of such risk factors and their potential effects.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward- looking information, except as required by applicable law.
Contacts:
Quantum BioPharma Ltd.
Zeeshan Saeed, Founder, CEO and Executive Co-Chairman of the Board
Email: Zsaeed@quantumbiopharma.com
Telephone: (833) 571-1811
Investor Relations: IR@QuantumBioPharma.com
General Inquiries: info@QuantumBioPharma.com
FAQ
What is the partnership between QNTM's licensee and AATAC for unbuzzd distribution?
How many retail locations will potentially carry unbuzzd through the AATAC partnership?
What are the claimed benefits of unbuzzd powder stick packs?
Which major retail chains are part of the AATAC network for unbuzzd distribution?
